Related Experiment Videos
Cardiovascular Complications of Neuromuscular Disorders
Bhavesh Sachdev1, Perry M. Elliott, William J. McKenna
1Department of Cardiological Sciences, St. George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, United Kingdom. wmckenna@sghms.ac.uk
Current Treatment Options in Cardiovascular Medicine
|February 23, 2002
Summary
Familial neuromuscular and cardiovascular diseases often stem from inherited mutations affecting muscle cell cytoskeletons. Early cardiac assessment and tailored therapies are crucial for managing these complex conditions.
Area of Science:
- Molecular Genetics
- Cardiology
- Neurology
Background:
- Advances in molecular genetics reveal shared pathophysiology between familial neuromuscular and cardiovascular diseases.
- Inherited mutations in the cellular cytoskeleton of muscle cells are the common underlying cause.
- Cardiac complications are frequently observed in patients with neuromuscular disorders.
Purpose of the Study:
- To highlight the common pathophysiology of familial neuromuscular and cardiovascular diseases.
- To emphasize the importance of cardiac assessment and management in neuromuscular disorders.
- To discuss specific cardiac complications and their therapeutic strategies.
Main Methods:
- Review of current literature on molecular genetics, neuromuscular diseases, and cardiovascular complications.
- Analysis of clinical manifestations and management strategies for cardiac involvement in neuromuscular disorders.
- Identification of common cardiac conditions such as dilated cardiomyopathy, conduction disturbances, and arrhythmias.
Main Results:
- Dilated cardiomyopathy is a frequent complication, manageable with standard heart failure therapies.
- Conduction disturbances pose a significant mortality risk, often requiring pacemaker implantation.
- Rhythm disturbances like atrial fibrillation and ventricular tachyarrhythmias necessitate careful management, considering patient-specific challenges.
- Hypertrophic cardiomyopathy, though uncommon, can also occur.
Conclusions:
- Integrated management involving periodic cardiac assessment and targeted therapies is essential for patients with neuromuscular diseases.
- Proactive identification and treatment of cardiac complications can improve outcomes and prevent mortality.
- Further research into the specific mechanisms and tailored treatments for these overlapping conditions is warranted.